Alzheimer's disease is a neurodegenerative disorder affecting the elderly and accounts for two thirds of all dementia. Recent epidemiological studies suggest that the use of non-steroidal anti-inflammatory agents is associated with a significantly lower risk of developing Alzheimer's disease. The primary targets of NSAIDs are the prostaglandin synthases, also known as cyclooxygenases. The cyclooxygenases catalyze the conversion of arachidonic acid to PGH2, which becomes the substrate for prostaglandin and thromboxane synthases. The conclusion raised by the recent epidemiological studies is that inhibition of cyclooxygenases activity is protective against development of Alzheimer's disease. There are two isoforms of cyclooxygenase (cox). Cox-1 is expressed constitutively in most tissues and at very low levels in the brain. Cox-2 is expressed in neurons of hipppocampus, amygdala and layers II/III of cortex. From our previous studies of genes involved in the adaptive responses of neurons to synaptic activity, we have identified cox-2 as an N-methyl D-aspartate (NMDA)-dependent activity-regulated gene in brain. Cox-2 is also highly expressed in neurons in paradigms of excitotoxicity, such as ischemia, trauma, and kindling. Because of its regulation by excitatory synaptic activity, and because of recent evidence implicating excitotoxic mechanisms in neurodegenerative diseases, we propose to study the role of cox-2 in the pathogenesis of Alzheimer's disease. We have generated transgenic C57Bl6/J founder mice that express the human form of cox-2 driven by the neuronal specific thy-1. An initial line of transgenic hcox-2 mice demonstrates immunoreactive hcox-2 and an 8 to 12-fold increase in PGE2 synthesis.
In Aim 1 we will complete our immunohistochemical and biochemical characterization of remaining lines generated from our founder mice and select 3-5 additional lines for further study.
In Aim 2 we will examine the contribution of cox-2 activity to the pathogenesis of Alzheimer's disease by crossing hcox-2 mice to a murine model of familial Alzheimer's disease that overexpresses mutant APP and PS-1 and analyzing the pathological phenotype of resultant double and triple transgenic mice.
In Aim 3, we will test the effect of a selective cox-2 inhibitor on the development of a pathological AD phenotype in single, bigenic and trigenic mice generated in Aims 1 and 2.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG015799-01A2
Application #
6200075
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Snyder, D Stephen
Project Start
2000-08-01
Project End
2003-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
1
Fiscal Year
2000
Total Cost
$286,984
Indirect Cost
Name
Johns Hopkins University
Department
Neurology
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Woodling, Nathaniel S; Andreasson, Katrin I (2016) Untangling the Web: Toxic and Protective Effects of Neuroinflammation and PGE2 Signaling in Alzheimer's Disease. ACS Chem Neurosci 7:454-63
Shi, Ju; Wang, Qian; Johansson, Jenny U et al. (2012) Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Ann Neurol 72:788-98
Andreasson, Katrin (2010) Emerging roles of PGE2 receptors in models of neurological disease. Prostaglandins Other Lipid Mediat 91:104-12
Liang, X; Wu, L; Wang, Q et al. (2007) Function of COX-2 and prostaglandins in neurological disease. J Mol Neurosci 33:94-9
Melnikova, T; Savonenko, A; Wang, Q et al. (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern. Neuroscience 141:1149-62
Boutaud, Olivier; Andreasson, Katrin I; Zagol-Ikapitte, Irene et al. (2005) Cyclooxygenase-dependent lipid-modification of brain proteins. Brain Pathol 15:139-42
Zagol-Ikapitte, Irene; Masterson, Tina S; Amarnath, V et al. (2005) Prostaglandin H(2)-derived adducts of proteins correlate with Alzheimer's disease severity. J Neurochem 94:1140-5
Dore, Sylvain; Otsuka, Takashi; Mito, Toshiaki et al. (2003) Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction. Ann Neurol 54:155-62
Vidensky, Svetlana; Zhang, Yan; hand, Tracey et al. (2003) Neuronal overexpression of COX-2 results in dominant production of PGE2 and altered fever response. Neuromolecular Med 3:15-28
Andreasson, K I; Savonenko, A; Vidensky, S et al. (2001) Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 21:8198-209